QIAGEN N.V. (QGEN)
Here's Why Qiagen (QGEN) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements
QGEN achieves milestone with more than 1,000 EZ2 Connect placements worldwide, contributing to a global installed base of over 5,500 EZ series instruments.
Should You Continue to Retain QIAGEN Stock in Your Portfolio Now?
QGEN's robust expansion of its testing menu and potential in molecular diagnostics bode well for investors.
Here's Why Qiagen (QGEN) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
QGEN Stock to Gain From Expanding QIAstat-Dx With New Barcelona Site
QIAGEN's new Barcelona site is set to drive QIAstat-Dx's growth in infectious diseases and precision medicine testing.
QGEN Stock Dips Despite Launch of Customized dPCR Assay Design Tools
QIAGEN introduces two new customizable dPCR assay design tools featuring advanced design algorithms tailored for diverse microbial applications and custom NGS panels.
Here's Why Qiagen (QGEN) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Innovations Support QIAGEN Shares Despite Macroeconomic Concerns
To support internal growth, QGEN heavily invests in R&D for the menu expansion of its key platforms.
Reasons to Retain QIAGEN Stock in Your Portfolio for Now
Investors feel optimistic about QGEN's growth prospects in the NGS platforms. Yet, an unfavorable currency impact on the company's operations is concerning.
QGEN Collaborates With McGill University Centre: Stock to Gain?
QIAGEN joins forces with McGill University Centre for Microbiome Research to generate evidence-based knowledge for medicine and public health.
Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock
Evaluate Qiagen's (QGEN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
